Translate:
If you would like to supply us with products...email MARK@SPOREBUDDIES.COM
0800 069 9269 / Whatsapp only (+44) 07495515023
EN
Translate:
If you would like to supply us with products...email MARK@SPOREBUDDIES.COM
0800 069 9269 / Whatsapp only (+44) 07495515023
EN
Signed in as:
filler@godaddy.com
Are you currently, or are planning to, microdose with a psychedelic? We are now recruiting for our new psychedelic microdosing study!
The Beckley/Imperial Psychedelic Reasearch Programme is excited to announce a new, self-blinded study on psycedelic microdosing.
Sign up for their News Letter HERE. Volunteer request will be announced via the news letter.
If you would like to have a look around their site click HERE
In 2016, the Beckley/Imperial Research Programme released a study that revealed the staggering potential of psilocybin to alleviate treatment-resistant depression, with 67 percent being depression free after one week and 42 percent remaining in remission three months later. Collaborating with highly prestigious universities, the Beckley Foundation has also conducted research indicating the efficacy of psilocybin as an aid to smoking cessation. Using the latest brain-imaging techniques, we have shed some light on how psilocybin may produce its therapeutic effects, by generating a more ‘entropic’ pattern of brain connectivity, with increased communication throughout the brain leading to more flexible modes of cognition.
Just click back to return to our site
Just click back to return to our site
Just click back to return to our site